Unknown

Dataset Information

0

A variant in the CASR gene (c.368T>C) causing hypocalcemia refractory to standard medical therapy.


ABSTRACT: Hypoparathyroidism is characterized by low or inappropriately normal parathormone production, hypocalcemia and hyperphosphatemia. Autosomal dominant hypocalcemia (ADH) type 1 is one of the genetic etiologies of hypoparathyroidism caused by heterozygous activating mutations in the calcium-sensing receptor (CASR) gene. Current treatments for ADH type 1 include supplementation with calcium and active vitamin D. We report a case of hypoparathyroidism in an adolescent affected by syncope without prodrome. The genetic testing revealed a variant in the CASR gene. Due to standard therapy ineffectiveness, the patient was treated with recombinant human parathyroid hormone (1-34), magnesium aspartate and calcitriol. He remained asymptomatic and without neurological sequelae until adulthood. Early diagnosis and treatment are important to achieve clinical stability. Autosomal dominant hypocalcemia (ADH) type 1 is one of the genetic etiologies of hypoparathyroidism caused by heterozygous activating mutations in the calcium-sensing receptor (CASR) gene. The variant c.368T>C (p.Leu123Ser) in heterozygosity in the CASR gene is likely pathogenic and suggests the diagnosis of ADH type 1. Teriparatide (recombinant human parathyroid hormone 1-34) may be a valid treatment option to achieve clinical stability for those individuals whose condition is poorly controlled by current standard therapy.

SUBMITTER: Festas Silva D 

PROVIDER: S-EPMC8686169 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

A variant in the CASR gene (c.368T>C) causing hypocalcemia refractory to standard medical therapy.

Festas Silva Diana D   De Sousa Lages Adriana A   Caetano Joana Serra JS   Cardoso Rita R   Dinis Isabel I   Gomes Leonor L   Paiva Isabel I   Mirante Alice A  

Endocrinology, diabetes & metabolism case reports 20211201


<h4>Summary</h4>Hypoparathyroidism is characterized by low or inappropriately normal parathormone production, hypocalcemia and hyperphosphatemia. Autosomal dominant hypocalcemia (ADH) type 1 is one of the genetic etiologies of hypoparathyroidism caused by heterozygous activating mutations in the calcium-sensing receptor (CASR) gene. Current treatments for ADH type 1 include supplementation with calcium and active vitamin D. We report a case of hypoparathyroidism in an adolescent affected by sync  ...[more]

Similar Datasets

| S-EPMC6669810 | biostudies-literature
| S-EPMC4906418 | biostudies-literature
| S-EPMC6361088 | biostudies-literature
| S-EPMC7219130 | biostudies-literature
| S-EPMC9280832 | biostudies-literature
| S-EPMC9388361 | biostudies-literature
| S-EPMC6057017 | biostudies-literature
| S-EPMC4541614 | biostudies-literature
2022-04-27 | GSE195577 | GEO
| S-EPMC11584096 | biostudies-literature